Robeco Institutional Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-498,309
| Closed | -$11M | – | 929 |
|
|
2024
Q4 | $11M | Buy |
498,309
+33,277
| +7% | +$733K | 0.02% | 437 |
|
|
2024
Q3 | $8.38M | Buy |
465,032
+197,585
| +74% | +$3.56M | 0.02% | 465 |
|
|
2024
Q2 | $4.35M | Buy |
267,447
+160,616
| +150% | +$2.61M | 0.01% | 561 |
|
|
2024
Q1 | $1.51M | Buy |
106,831
+31,271
| +41% | +$441K | ﹤0.01% | 729 |
|
|
2023
Q4 | $789K | Hold |
75,560
| – | – | ﹤0.01% | 803 |
|
|
2023
Q3 | $771K | Sell |
75,560
-56,776
| -43% | -$579K | ﹤0.01% | 805 |
|
|
2023
Q2 | $996K | Buy |
132,336
+41,438
| +46% | +$312K | ﹤0.01% | 786 |
|
|
2023
Q1 | $804K | Hold |
90,898
| – | – | ﹤0.01% | 803 |
|
|
2022
Q4 | $829K | Buy |
+90,898
| New | +$829K | ﹤0.01% | 796 |
|